TY  - GEN
AU  - Kennedy,M J
AU  - Armstrong,D K
AU  - Huelskamp,A M
AU  - Ohly,K
AU  - Clarke,B V
AU  - Colvin,O M
AU  - Grochow,L B
AU  - Chen,T L
AU  - Davidson,N E
TI  - Phase I and pharmacologic study of the alkylating agent modulator novobiocin in combination with high-dose chemotherapy for the treatment of metastatic breast cancer
SN  - 0732-183X
PY  - 1995///0605
KW  - Adult
KW  - Anemia, Aplastic
KW  - chemically induced
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cyclophosphamide
KW  - administration & dosage
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - Drug Resistance
KW  - Female
KW  - Gastrointestinal Diseases
KW  - Humans
KW  - Length of Stay
KW  - Lymphatic Metastasis
KW  - Middle Aged
KW  - Mouth Mucosa
KW  - drug effects
KW  - Neutropenia
KW  - Novobiocin
KW  - Prospective Studies
KW  - Stomatitis
KW  - Thiotepa
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1200/JCO.1995.13.5.1136
ER  -